Go to content
UR Home

Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis

URN to cite this document:
DOI to cite this document:
Wertheimer, Tobias ; Dohse, Marius ; Afram, Gabriel ; Weber, Daniela ; Heidenreich, Martin ; Holler, Barbara ; Kattner, Anna-Sophia ; Neubauer, Andreas ; Mielke, Stephan ; Ljungman, Per ; Holler, Ernst ; Herr, Wolfgang ; Edinger, Matthias ; Martínez, Antonio Pérez ; Fante, Matthias ; Wolff, Daniel
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 05 Aug 2022 06:27

This publication is part of the DEAL contract with Springer.


The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of abatacept for cGvHD therapy in a retrospective study with 15 patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) and received abatacept ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons